Skip to search formSkip to main contentSkip to account menu

Sch 39304

Known as: Sch-39304 
National Institutes of Health

Related topics

Related topics

6 relations

Broader (3)

Antifungal AgentsTriazolesgenaconazole

Narrower (3)

SM 8668Sch 42426Sch 42427

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1994
1994
Treatment of coccidioidomycosis with SCH 39304.
A new oral triazole antifungal, SCH 39304, was administered to 54 patients with progressive infections due to Coccidioides… 
1993
1993
IL-4, IgE, and interferon-gamma production in pulmonary blastomycosis: comparison in mice untreated, immunized, or treated with an antifungal (SCH 39304).
The purpose of this study was to determine if there is a correlation between production of certain lymphokines in progressive… 
1992
1992
In vitro and in vivo activities of SCH 42427, the active enantiomer of the antifungal agent SCH 39304
SCH 39304, a new triazole antifungal agent, is a 50:50 racemic mixture of two enantiomers, SCH 42427 and SCH 42426. The… 
1991
1991
Treatment of murine cryptococcal meningitis with an SCH 39304-amphotericin B combination
Cryptococcal meningitis was induced in BALB/c mice by intracerebral infection with Cryptococcus neoformans. Drug therapy was… 
1991
1991
Interactions of amphotericin B and SCH 39304 in the treatment of experimental murine candidiasis: lack of antagonism of a polyene-azole combination
Mice infected intravenously with Candida albicans were treated with SCH 39304, a new triazole antifungal compound, amphotericin B… 
1991
1991
Efficacy of SCH 39304 in treatment of experimental invasive aspergillosis
The efficacy of SCH 39304 (SCH) against Aspergillus fumigatus was assessed with an immunosuppressed, temporarily leukopenic… 
1991
1991
Treatment of experimental cryptococcosis with SCH 39304 and fluconazole
The efficacy of two triazoles, SCH 39304 and fluconazole, in the treatment of disseminated cryptococcosis in Wistar rats was… 
1990
1990
SCH-39304 in prevention and treatment of disseminated candidiasis in persistently granulocytopenic rabbits
To investigate the potential use of SCH-39304 for the prevention and treatment of disseminated candidiasis in granulocytopenic… 
1990
1990
In vivo efficacy of SM-8668 (Sch 39304), a new oral triazole antifungal agent
SM-8668 (Sch 39304) is a new oral antifungal agent which we evaluated in comparison with fluconazole in various fungal infection… 
1989
1989
Pharmacokinetics and tissue penetration of Sch 39304 in granulocytopenic and nongranulocytopenic rabbits
We studied the plasma pharmacokinetics and tissue penetration of Sch 39304 (SCH), a new antifungal triazole, in granulocytopenic… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)